Eric Rubin, MD, Discusses How the AACR Contributes to Advances for Patients

AACR membership includes scientists and physicians from across the cancer research enterprise. Whether basic, translational, or clinical researchers, they all share the same goal: to make progress for patients. In this post, Eric Rubin, MD, deputy editor of Clinical Cancer Research, one of the AACR’s eight journals, shares his thoughts on the AACR’s role in developing breakthrough cancer treatments.

Read More

Stepping Into the Era of Combination Cancer Therapies, Part 1: Combining Immunotherapies

Game-changing modern cancer therapies—immunotherapies and targeted therapies, among others—have been providing promising treatment outcomes in the recent years. The outcomes with immunotherapies, in particular, are so compelling that cancer clinicians …

Read More

Mastering the Clinical Development of Personalized Cancer Medicines

A string of innovative clinical trials designed to accelerate the pace at which personalized cancer medicines are developed have been announced, and in some cases initiated, over the past few …

Read More